⁷[CHAPTER 30 

PHARMACEUTICAL PRODUCTS
(Section Notes)

Main Notes

1 This Chapter does not cover:

(a) foods or beverages(suchas dietetic, diabeticorfortified foods,food supplements,tonic beverages and mineral waters), other than nutritional preparations for intravenous administration (Section IV);

(b) products, such as tablets, chewing gum or patches (transdermal systems), containing nicotine and intended to assist tobacco use cessation (heading 2404);

(c) plasters specially calcined or finely ground for use in dentistry (heading 2520);

(d) aqueous distillates or aqueous solutions of essential oil, suitable for medicinal uses (heading 3301);

(e) preparations of headings 3303 to 3307, even if they have therapeutic or prophylactic properties;

(f) soap or other products of heading 3401 containing added medicaments;

(g) preparations with a basis of plaster for use in dentistry (heading 3407);

(h) blood albumin not prepared for therapeutic or prophylactic uses (heading 3502); or.

(ij) diagnostic reagents of heading 3822.

2 For the purposes of heading 3002, the expression "immunological products" appliesto peptides and proteins (other than goods of heading 2937) which are directly involved in the regulation of immunological processes, such as monoclonal antibodies (MAB), antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFN), chemokines and certain tumor necrosis factors (TNF), growth factors(GF), hematopoietins and colony stimulating factors(CSF).;

3 For the purposes of headings 3003 and 3004 and of Note 4(d) to this Chapter, the following are to be treated:

(a) as unmixed products:

(1) unmixed products dissolved in water;

(2) all goods of Chapter 28 or 29; and

(3)simple vegetable extracts of heading1302,merelystandardised or dissolved in any solvent;

(b) as products which have been mixed:

(1) colloidalsolutions and suspensions(other than colloidalsulphur);

(2) vegetable extracts obtained by the treatment of mixture of vegetable materials; and

(3) salts and concentrates obtained by evaporating natural mineral waters.

4 Heading 3006 applies only to the following, which are to be classified in that heading and in no other heading of this Schedule—

(a) sterile surgical catgut,similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure;

(b) sterile laminaria and sterile laminaria tents;

(c) sterile absorbable surgical or dental haemostatics sterile surgical or dental adhesion barriers, whether or not absorbable;

(d) opacifying preparations for X-ray examinations and diagnostic reagents designed to be administered to the patient, being unmixed products put up in measured doses or products consisting of two or more ingredients which have been mixed together for such uses;

(e) placebos and blinded (or double-blinded) clinical trial kits for use in recognized clinical trials, put up in measured doses, even if they might contain active medicaments;

(f) dental cements and other dental fillings; bone reconstruction cements;

(g) first-aid boxes and kits;

(h) chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides;

(i) gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments; and

(j) waste pharmaceuticals, that is, pharmaceutical products which are unfit for their original intended purpose due to, for example, expiry ofshelf-life.

(k) appliancesidentifiable for ostomy use, that is, colostomy, ileostomy and urostomy pouches cut to shape and their adhesive wafers or faceplates.

Sub-Heading Notes

1 For the purposes of sub-headings 3002 13 and 3002 14, the following are to be treated:

(a) as unmixed products, pure products, whether or not containing impurities;

(b) as products which have been mixed:

(1) the products mentioned in (a) above dissolved in water or in other solvents;

(2) the products mentioned in (a) and (b) (1) above with an added stabiliser necessary for their preservation or transport; and

(3) the products mentioned in (a), (b) (1) and (b) (2) above with any other additive.

2 Sub-headings 3003 60 and 3004 60 cover medicaments containing artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or containing any of the following active principles, whether or not combined with other pharmaceutical active ingredients: amodi aquine (INN); artelinic acid oritssalts; artenimol(INN); artemotil(INN); artemether(INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN);mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN).

Policy Conditions

1 (i) Cough Syrup shall be permitted to be exported subject to the export sample being tested and production of Certificate of Analysis (CoA) issued by any of the following laboratories:
Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh CDL, Kolkata, West Bengal CDTL, Chennai, Tamil Nadu CDTL, Mumbai, Maharashtra CDTL, Hyderabad, Telangana RDTL, Chandigarh RDTL, Guwahati, Assam Any NABL accredited State Drugs Testing Laboratory Bee Pharmo Labs Pvt. Ltd Thane, C2 Hatkesh Udyog Nagar, Mira Bhayander Road, Mira Road(East), Thane-401107, Maharstra Oasis Test House, 24-A, B Sardar Patel, Industrial Estate, Narol, Ahmedabad-382407, Gujrat Shriram Institute of Industria Research (A unit of Shriram Scientific and Indutrial Research Foundation), 19-University Road, New Delhi-110007

(ii) In case, the manufecturers are exporting the Cough Syrup to USA, UK, Canada, EU, Japan, Australia, Singapore, Republic of Korea and Switzerland, the requirement of testing from the laboratories mentioned at (i) above may be waived off, in view of approval granted by these countries' regulatory agencies for plant/section engaged in manufecturing and export of Cough Syrup.

(iii) Further, if Cough Syrup is manufectured in a plant/section approved by regulatory agencies for above mentioned countries at (ii) for any product, such Cough Syrup shall be permitted to be exported to any country without testing as mendated at (i) above.

2 Exports of Derivatives, extracts and formulations is free, subject to the provisions of Wild Life (Protection) Act, 1972 and “CITES”

3 Exports of All wild animals, animal articles including their products and derivatives excluding those for which ownership certificates have been granted and also those required for transactions for education, scientific research and management under Wild Life (Protection) Act, 1972 including their parts and products are Prohibited and not permitted to be exported

4 Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS

5 Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor.

6 1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO.
2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.

Export Licensing Notes

1 “The words ‘ Heavy metals within permissible limits’ have be conspicuously displayed on the container of purely Herbal Ayurveda, Siddha and Unani medicines to be exported. Alternatively, a Certificate that ‘ Heavy metals within permissible limits ‘ issued either by an inhouse laboratory fully equipped with appropriate equipments for testing heavy metals or by any other NABL / GLP accredited laboratory or any other approved laboratory has to be produced along with other consignment papers.”

2 Formulations of plant portions of prohibited varieties falling in heading 3003 and heading 3004 are freely exportable subject to conditions. For details, please see chapter 12

]

^[helldodold[⁴[CHAPTER 30
PHARMACEUTICAL

Main Notes

1 “The words ‘ Heavy metals within permissible limits’ have be conspicuously displayed on the container of purely Herbal Ayurveda, Siddha and Unani medicines to be exported. Alternatively, a Certificate that ‘ Heavy metals within permissible limits ‘ issued either by an inhouse laboratory fully equipped with appropriate equipments for testing heavy metals or by any other NABL / GLP accredited laboratory or any other approved laboratory has to be produced along with other consignment papers.”

2 Formulations of plant portions of prohibited varieties falling in heading 3003 and heading 3004 are freely exportable subject to conditions. For details, please see chapter 12

⁶[1 (i) Cough Syrup shall be permitted to be exported subject to the export sample being tested and production of Certificate of Analysis (CoA) issued by any of the following laboratories:

• Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh
• CDL, Kolkata, West Bengal
• CDTL, Chennai, Tamil Nadu
• CDTL, Mumbai, Maharashtra
• CDTL, Hyderabad, Telangana
• RDTL, Chandigarh
• RDTL, Guwahati, Assam
• Any NABL accredited State Drugs Testing Laboratory
• Bee Pharmo Labs Pvt. Ltd Thane, C 2 Hatkesh Udyog Nagar, Mira Bhayander Road, Mira Road (East), thane-401107, Maharastra.
• Oasis Test House, 24-A, B Sardar Patel, industrial Estate, Narol, Ahmedabad382407, Gujarat.
• Shriram Institute for Industrial Research (A unit of Shriram Scientific and Industrial Research  Foundation), 19-University Road, New Delhi-110007

(ii) In case, the manufacturers are exporting the Cough Syrup to USA, UK, Canada, EU, Japan, Australia, Singapore, Republic of Korea and Switzerland, the requirement of testing from the laboratories mentioned at (i) above may be waived off, in view of approval granted by these countries’ regulatory agencies for plants/section engaged in manufacturing and export of Cough Syrup.

(iii) Further, if Cough Syrup is manufactured in a plant/section approved by the regulatory agencies for above mentioned countries at (ii) for any product, such Cough Syrup shall be permitted to be exported to any country without testing as mandated at (i) above.]

^[helldodold[1 Cough Syrup shall be permitted to be exported subject to the export sample being tested and production of Certificate of Analysis (CoA) issued by any of the following laboratories: Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh

CDL, Kolkata, West Bengal

CDTL, Chennai, Tamil Nadu

CDTL, Mumbai, Maharashtra

CDTL, Hyderabad, Telangana

RDTL, Chandigarh

RDTL, Guwahati, Assam

Any NABL accredited State Drugs Testing Laboratory]^helldod]

2 Exports of Derivatives, extracts and formulations is free, subject to the provisions of Wild Life (Protection) Act, 1972 and “CITES”

3 Exports of All wild animals, animal articles including their products and derivatives excluding those for which ownership certificates have been granted and also those required for transactions for education, scientific research and management under Wild Life (Protection) Act, 1972 including their parts and products are Prohibited and not permitted to be exported
 

Chapter Number	ITC-HS Codes	Description	Dashes	Export Policy	Policy Condition	Notification No	Notification Date
30	30	Pharmaceutical Products.		Prohibited	Export of All wild animals, animal articles including their products and derivatives excluding those for which ownership certificates have been granted and also those required for transactions for education, scientific research and management under Wild Life (Protection) Act, 1972 including their parts and products is Prohibited and not permitted to be exported
30	3001	Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included.		Free		56/2015-20	24.02.2022
30	300120	Extracts of glands or other organs or of their secretions	-
30	30012010	Liquid extracts of liver	---	Free
30	30012020	Liver extracts, dry	---	Free
30	30012030	Snake Venom	---	Free
30	30012090	Other	---	Free	However, the following items are Restricted for exports and permitted under License: 1. Gonads and other reproductive organs of buffaloes 2. Germplasm of cattle and buffaloes
30	300190	Other	-
30	30019010	Of human origin	---	Free
30	30019091	Other: ---- Heparin and its salts	---	Free	Export of Heparin and its salts is Free wherein export of the item produced from animal by-products allowed freely but export to European Union allowed subject to the following conditions : (i) A ‘Shipment Clearance Certificate’ is to be issued consignment-wise by the CAPEXIL indicating details of the name and address of the exporter, address of the registered plant, IEC No. of the exporter, Plant approval number, nature of export product, quantity, invoice number and date, port of loading (name of the port) and destination; (ii) After the shipment is made, the exporter shall also provide a ‘Health Certificate’ consignment-wise to the buyer giving details of the product with HS Code, packaging, its origin, destination, vessel name, date of departure, health requirements, etc. This Health Certificate would be issued jointly by CAPEXIL and Regional Animal Quarantine Officer, Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture and Farmers Welfare, Government of India.	34/2015-20	13.01.2017
30	30019099	Other: ---- Other	---	Free	However, the following items are Restricted for exports and permitted under License: 1. Gonads and other reproductive organs of buffaloes 2. Germplasm of cattle and buffaloes
30	3002	HUMAN BLOOD; ANIMAL BLOOD PREPARED FORTHERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES,TOXINS, CULTURES OF MICROORGANISMS (EXCLUDING YEASTS) AND ETHER SIMILAR PRODUCTS; CELL CULTURES, WHETHER OR NOT MODIFIED		Free		56/2015-20	24.02.2022
30	300210	Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
30	30021020	Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes	---	5[Free subject NOC] [helldodold[Free]helldod]	5[1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Exports of Gamma globulin and human serum albumin manufactured from human placenta and human placental blood is free. 3. Export of Antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes and Hemoglobin blood globulins and serum globulins is free wherein Export of the item produced from animal by-products is allowed freely but export to European Union allowed subject to the following conditions : (i) A ‘Shipment Clearance Certificate’ is to be issued consignment-wise by the CAPEXIL indicating details of the name and address of the exporter, address of the registered plant, IEC No. of the exporter, Plant approval number, nature of export product, quantity, invoice number and date, port of loading (name of the port) and destination; (ii) After the shipment is made, the exporter shall also provide a ‘Health Certificate’ consignment-wise to the buyer giving details of the product with HS Code, packaging, its origin, destination, vessel name, date of departure, health requirements, etc. This Health Certificate would be issued jointly by CAPEXIL and Regional Animal Quarantine Officer, Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture and Farmers Welfare, Government of India.]helldod]	34/2015-20	13.01.2017
30	30021091	Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes	---	5[Free subject NOC] [helldodold[Free]helldod]	5[1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Exports of Gamma globulin and human serum albumin manufactured from human placenta and human placental blood is free. 3. Export of Antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes and Hemoglobin blood globulins and serum globulins is free wherein Export of the item produced from animal by-products is allowed freely but export to European Union allowed subject to the following conditions : (i) A ‘Shipment Clearance Certificate’ is to be issued consignment-wise by the CAPEXIL indicating details of the name and address of the exporter, address of the registered plant, IEC No. of the exporter, Plant approval number, nature of export product, quantity, invoice number and date, port of loading (name of the port) and destination; (ii) After the shipment is made, the exporter shall also provide a ‘Health Certificate’ consignment-wise to the buyer giving details of the product with HS Code, packaging, its origin, destination, vessel name, date of departure, health requirements, etc. This Health Certificate would be issued jointly by CAPEXIL and Regional Animal Quarantine Officer, Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture and Farmers Welfare, Government of India.]helldod]
30	300212	Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes -- Antisera and other blood fractions	-
30	30021210	For diphtheria	---	5[Free subject NOC] [helldodold[Free]helldod]	5[1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor.]helldod]
30	30021220	For tetanus	---	5[Free subject NOC] [helldodold[Free]helldod]	5[1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor.]helldod]
30	30021230	For rabies	---	5[Free subject NOC] [helldodold[Free]helldod]	5[1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS]helldod]
30	30021240	For snake venom	---	5[Free subject NOC] [helldodold[Free]helldod]	5[1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS]helldod]
30	30021290	Other	---	5[Free subject NOC] [helldodold[Free]helldod]	5[1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor.]helldod]
30	30021300	Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale	- -	Free
30	30021400	Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale	- -	Free
30	30021500	Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes -- Immunological products, put up in measured doses or in forms or packings for retail sale	-	Free
30	300241	Vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - - Vaccines for human medicine:
30	30024111	Single vaccines for: - - - - Cholera and typhoid	- - -	Free
30	30024112	Single vaccines for: - - - - Hepatitis	- - -	Free
30	30024113	Single vaccines for: - - - - Tetanus	- - -	Free
30	30024114	Single vaccines for: - - - - Polio	- - -	Free
30	30024115	Single vaccines for: - - - - Tuberculosis	- - -	Free
30	30024116	Single vaccines for: - - - - Rabies	- - -	Free
30	30024117	Single vaccines for: - - - - Japanese encephalitis	- - -	Free
30	30024118	Single vaccines for: - - - - Whopping cough (pertussis)	- - -	Free
30	30024119	Single vaccines for: - - - - Other	- - -	Free
30	30024121	Diphtheria, pertussis andtetanus (DPT)	- - - -	Free
30	30024122	Mixed vaccines for: - - - - Diphtheria and tetanus (DT)	- - -	Free
30	30024123	Mixed vaccines for: - - - - Measles, mumps and rubella (MMR)	- - -	Free
30	30024124	Mixed vaccines for: - - - - Typhoid-paratyphoid (TAB)	- - -	Free
30	30024125	Mixed vaccines for: - - - - Typhoid-paratyphoid-cholera (TABC)	- - -	Free
30	30024129	Mixed vaccines for: - - - - Other	- - -	Free
30	30024200	Mixed vaccines for: - - Vaccines for veterinary medicine	- - -	Free
30	300249	Mixed vaccines for: - - Other
30	30024910	Mixed vaccines for: - - - Cultures of micro-organisms (excluding yeast)	- - -	Free
30	30024920	Mixed vaccines for: - - - Toxins	- - -	Free
30	30024990	Mixed vaccines for: - - - Other	- - -	Free
30	30025100	Cell cultures, whether or not modified - - Cell therapy products	-	Free
30	30025900	Cell cultures, whether or not modified - - Other	-	Free
30	300290	Other	-
30	30029010	Human blood	---	5[Free subject NOC] [helldodold[Free]helldod]	5[1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor.]helldod]
30	30029020	Animal blood prepared for therapeutic, prophylactic or diagnostic uses	---	Free	1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor.
30	30029090	Other	---	Free
30	3003	Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
30	30031000	Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives	-	Free
30	30032000	Other, containing antibiotics	-	Free
30	30033100	Other, containing hormones or other products of heading 29.37 : -- Containing insulin	-	Free
30	30033900	Other, containing hormones or other products of heading 29.37 : -- Other	-	Free
30	30034100	Other, containing alkaloids or derivatives thereof : -- Containing ephedrine or its salts	-	Free	Subject to Policy Condition 2 of the Chapter
30	30034200	Other, containing alkaloids or derivatives thereof : -- Containing pseudoephedrine (INN) or its salts	-	Free	Subject to Policy Condition 2 of the Chapter
30	30034300	Other, containing alkaloids or derivatives thereof : -- Containing norephedrine or its salts	-	Free	Subject to Policy Condition 2 of the Chapter
30	30034900	Other, containing alkaloids or derivatives thereof : -- Other	-	Free	Subject to Policy Condition 2 of the Chapter
30	30036000	Other, containing antimalarial active principles described in Subheading Note 2 to this Chapter	-	Free
30	300390	Other	-
30	30039011	Ayurvedic, Unani, siddha, Homoeopathic or bio-chemic systems medicaments: ---- Of Ayurvedic System	---	Free	Subject to Policy Condition 2 of the Chapter
30	30039012	Ayurvedic, Unani, siddha, Homoeopathic or bio-chemic systems medicaments: ---- Of Unani systems	---	Free	Subject to Policy Condition 2 of the Chapter
30	30039013	Ayurvedic, Unani, siddha, Homoeopathic or bio-chemic systems medicaments: ---- Of Siddha system	---	Free	Subject to Policy Condition 2 of the Chapter
30	30039014	Ayurvedic, Unani, siddha, Homoeopathic or bio-chemic systems medicaments: ---- Of Homoeopathic System	---	Free	Subject to Policy Condition 2 of the Chapter
30	30039015	Ayurvedic, Unani, siddha, Homoeopathic or bio-chemic systems medicaments: ---- Of Bio-chemic system	---	Free	Subject to Policy Condition 2 of the Chapter
30	30039021	Menthol crystals and Milk of Magnesia: ---- Menthol crystals	---	Free
30	30039022	Menthol crystals and Milk of Magnesia: ---- Milk of Magnesia	---	Free
30	30039031	Bovine Albumin and drugs of animal origin, Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside, Anaesthetic agents used in human or veterinary medicine or surgery, Aluminium hydroxide gel: ---- Bovine Albumin and drugs of animal origin	---	Free
30	30039032	Bovine Albumin and drugs of animal origin, Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside, Anaesthetic agents used in human or veterinary medicine or surgery, Aluminium hydroxide gel: ---- Merbromine National Formulary XII (mercurochrome)	---	Free
30	30039033	Bovine Albumin and drugs of animal origin, Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside, Anaesthetic agents used in human or veterinary medicine or surgery, Aluminium hydroxide gel: ---- Calcium Sennoside	---	Free
30	30039034	Bovine Albumin and drugs of animal origin, Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside, Anaesthetic agents used in human or veterinary medicine or surgery, Aluminium hydroxide gel: ---- Anaesthetic agents used in human or veterinary medicine or surgery	---	Free
30	30039035	Bovine Albumin and drugs of animal origin, Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside, Anaesthetic agents used in human or veterinary medicine or surgery, Aluminium hydroxide gel: ---- Aluminium hydroxide gel	---	Free
30	30039036	Bovine Albumin and drugs of animal origin, Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside, Anaesthetic agents used in human or veterinary medicine or surgery, Aluminium hydroxide gel: ---- Ketamine	---	Free	Free, However export of Ketamine is allowed subject to obtaining No Objection Certificate from Narcotics Commissioner
30	30039090	Bovine Albumin and drugs of animal origin, Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside, Anaesthetic agents used in human or veterinary medicine or surgery, Aluminium hydroxide gel: ---- Other	---	Free
30	3004	Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale.		Free
30	300410	containing Penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives	-	Free
30	30041010	Penicillins	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30041020	Ampicillin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30041030	Amoxycillin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30041040	Becampicillin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30041050	Cloxacillin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30041060	Ampicillin and Cloxacillin combinations	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30041070	Streptomycin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30041090	Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	300420	Other, containing antibiotics	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042011	Cephalosporins and their derivatives: ---- Cefazolin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042012	Cephalosporins and their derivatives: ---- Cephalexin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042013	Cephalosporins and their derivatives: ---- Ciprofloxacin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042014	Cephalosporins and their derivatives: ---- Cefoxitin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042019	Cephalosporins and their derivatives: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042020	Cephalosporins and their derivatives: ---- Sulfonamides and Cotrimoxazole	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042031	Fluoroquinolones: ---- Norfloxacin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042032	Fluoroquinolones: ---- Nalidixic acid	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042033	Fluoroquinolones: ---- Ciprofloxacin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042034	Fluoroquinolones: ---- Ofloxacin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042039	Fluoroquinolones: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042041	Tetracyclines: ---- Chlortetracycline	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042042	Tetracyclines: ---- Oxytetracycline	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042049	Tetracyclines: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042050	Tetracyclines: ---- Chloramphenicol	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042061	Macrolide: ---- Erythromycin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042062	Macrolide: ---- Roxithromycin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042063	Macrolide: ---- Clarithromycin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042064	Macrolide: ---- Azithromycin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042069	Macrolide: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042070	Macrolide: ---- Cefadroxil	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042091	Other: ---- Isoniazid	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042092	Other: ---- Rifampicin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042093	Other: ---- Pyrazinamide	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042094	Other: ---- Ethambutol	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042095	Other: ---- Clindamycin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042096	Other: ---- Vancomycin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042097	Other: ---- Polymyxin B and Colistin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30042099	Other: ---- Hormones or other products	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	300431	Other, containing hormones or other products of heading 29.37 : -- Containing insulin	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043110	Insulin injection	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043190	Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043200	Other, containing hormones or other products of heading 29.37 : -- Containing corticosteroid hormones, their derivatives or structural analogues	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	300439	Other, containing hormones or other products of heading 29.37 : -- Other	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043911	Pituitary hormones; Prednisolone; Dexamethasone; Danazol; Other progestogen and oestogen group hormones: ---- Pituitary hormones	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043912	Pituitary hormones; Prednisolone; Dexamethasone; Danazol; Other progestogen and oestogen group hormones: ---- Prednisolone	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043913	Pituitary hormones; Prednisolone; Dexamethasone; Danazol; Other progestogen and oestogen group hormones: ---- Dexamethasone	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043914	Pituitary hormones; Prednisolone; Dexamethasone; Danazol; Other progestogen and oestogen group hormones: ---- Danazol	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043919	Pituitary hormones; Prednisolone; Dexamethasone; Danazol; Other progestogen and oestogen group hormones: ---- Other progestogen and oestogen group hormones	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043921	Gonadotrophins and luteinising hormone: ---- Gonadotrophins	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043922	Gonadotrophins and luteinising hormone: ---- Luteinising hormone	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30043990	Gonadotrophins and luteinising hormone: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044100	Other, containing alkaloids or derivatives thereof : -- Containing ephedrine or its salts	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044200	Other, containing alkaloids or derivatives thereof : -- Containing pseudoephedrine (INN) or its salts	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044300	Other, containing alkaloids or derivatives thereof : -- Containing norephedrine or its salts	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	300449	Other, containing alkaloids or derivatives thereof : -- Other	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044910	Atropine and salts thereof	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044920	Caffeine and salts thereof	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044930	Codeine and derivatives, with or without ephedrine hydrochloride	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044940	Ergot preparations, ergotamine and salts thereof	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044950	Papavarine hydrochloride	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044960	Bromohexin and salbutamol	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044970	Theophylline and salts thereof	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30044990	Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	300450	Other, containing vitamins or other products of heading 29.36	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045010	Heamatinics and Erythropoyetin preperations	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045020	Preperations of minerals and their supplements	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045031	Preparations of vitamins: ---- Of Vitamin A	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045032	Preparations of vitamins: ---- Of Vitamin B1 and B2 and their salts thereof	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045033	Preparations of vitamins: ---- Of Vitamin B9	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045034	Preparations of vitamins: ---- Of Vitamin B12	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045035	Preparations of vitamins: ---- Of Vitamin C	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045036	Preparations of vitamins: ---- Of Vitamin D	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045037	Preparations of vitamins: ---- Of Vitamin E	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045039	Preparations of vitamins: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30045090	Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30046000	Other, containing antimalarial active principles described in Subheading Note 2 to this Chapter	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	300490	Other	-	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049011	Ayurvedic, Unani, Homoeopathic, Siddha or Bio-chemic systems medicaments, put up for retail sale: ---- Of Ayurvedic System	---	Free	Subject to Policy Condition 1&2 of the Chapter	06/2023	22.05.2023
30	30049012	Ayurvedic, Unani, Homoeopathic, Siddha or Bio-chemic systems medicaments, put up for retail sale: ---- Of Unani systems	---	Free	Subject to Policy Condition 1&2 of the Chapter	06/2023	22.05.2023
30	30049013	Ayurvedic, Unani, Homoeopathic, Siddha or Bio-chemic systems medicaments, put up for retail sale: ---- Of Siddha system	---	Free	Subject to Policy Condition 1&2 of the Chapter	06/2023	22.05.2023
30	30049014	Ayurvedic, Unani, Homoeopathic, Siddha or Bio-chemic systems medicaments, put up for retail sale: ---- Of Homoeopathic System	---	Free	Subject to Policy Condition 1&2 of the Chapter	06/2023	22.05.2023
30	30049015	Ayurvedic, Unani, Homoeopathic, Siddha or Bio-chemic systems medicaments, put up for retail sale: ---- Of Bio-chemic system	---	Free	Subject to Policy Condition 1&2 of the Chapter	06/2023	22.05.2023
30	30049021	Anthelmintics drugs; Antiamoebic and other Antiprotozal drugs; Antifungal drugs: ---- Anthelmintics and preparations thereof	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049022	Anthelmintics drugs; Antiamoebic and other Antiprotozal drugs; Antifungal drugs: ---- Metronidazole	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049023	Anthelmintics drugs; Antiamoebic and other Antiprotozal drugs; Antifungal drugs: ---- Tinidazole	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049024	Anthelmintics drugs; Antiamoebic and other Antiprotozal drugs; Antifungal drugs: ---- Secnidazole	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049025	Anthelmintics drugs; Antiamoebic and other Antiprotozal drugs; Antifungal drugs: ---- Diloxamide Furoate	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049026	Anthelmintics drugs; Antiamoebic and other Antiprotozal drugs; Antifungal drugs: ---- Sodium Stibogluconate	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049027	Anthelmintics drugs; Antiamoebic and other Antiprotozal drugs; Antifungal drugs: ---- Pentamidine	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049029	Anthelmintics drugs; Antiamoebic and other Antiprotozal drugs; Antifungal drugs: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049031	Antihistaminics drugs; Antacids preparations; Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Promethazine, Chlorphenimiramine, Astemizole and Ceteirizine	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049032	Antihistaminics drugs; Antacids preparations; Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Sodium bicarbonate, Magnesium hydroxide (Milk of Magnesia), Magnesium carbonate, Magnesium trisilicate, Aluminium hydroxide gel, Magaldarate and combinations thereof	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049033	Antihistaminics drugs; Antacids preparations; Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Cimetidine, Rantidine, Nizatidine and Roxatidine	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049034	Antihistaminics drugs; Antacids preparations; Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Omeprazole and Lansoprazole	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049035	Antihistaminics drugs; Antacids preparations; Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Dicyclomine, Metoclopramide and Dexamethasone and Ondansetron	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049036	Antihistaminics drugs; Antacids preparations; Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Chenodiol and Ursodiol	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049039	Antihistaminics drugs; Antacids preparations; Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049041	Anticancer drugs: ---- Cyclophosphamide	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049042	Anticancer drugs: ---- Methotrexate, 5-fluorouracil(5FU) and Ftorafur	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049043	Anticancer drugs: ---- Bincristine and Vinblastine	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049044	Anticancer drugs: ---- Paclitaxel and Docetaxel	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049045	Anticancer drugs: ---- Etoposide	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049046	Anticancer drugs: ---- Actinomycin D-Dactinomycin and Doxorubicin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049047	Anticancer drugs: ---- L-Asparaginase, Cisplatin and Carboplatin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049048	Anticancer drugs: ---- Tamoxifen	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049049	Anticancer drugs: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049051	Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Isoniazid	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049052	Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Rifampicin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049053	Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Pyrazimamide and Ethambutol	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049054	Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Streptomycin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049055	Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Dapsone(DDS), Acedapsone (DADDS), Solopsone and Clofazimine	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049056	Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Chloroquine, Amodiaquine, Mefloquine, Quinine, Chloroguamamide, Pyrimethamine	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049057	Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Other Antitubercular drugs	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049058	Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Other Antileprotic drugs	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049059	Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Other Antimalarial drugs	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049061	Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Analgin with or without other compounds such as paracetamol	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049062	Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Acetyl salicylic acid (Aspirin) and formulations thereof	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049063	Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Ibuprofen with or without paracetamol or other compunds	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049064	Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Oxyphen butazone, Phenyl butazone and formulations thereof	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049065	Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Indomethacin	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049066	Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Mephenamic acid, dactofenac sodium, Piroxicam, Tenoxicam and Meloxicam	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049067	Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Ketorolac, Nimesulide, Mabumetone and Nefopam	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049069	Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049071	Antihepertensive drugs: ---- Captopril, Enalapril, Lisimopril, Perimdopril and Ramipril	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049072	Antihepertensive drugs: ---- Verapamil, Nifedipine, Amlodipine and Lacidipine	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049073	Antihepertensive drugs: ---- Losartam	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049074	Antihepertensive drugs: ---- Propranolol, Metoprolol, Atenolol and Labetalol	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049075	Antihepertensive drugs: ---- Prazosin, Terazosin, Phentolamine and Phenoxybenzamime	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049076	Antihepertensive drugs: ---- Clonidine, Methyldopa	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049077	Antihepertensive drugs: ---- Hydralazine, Minoxidil and Diazoxide	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049079	Antihepertensive drugs: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049081	Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Phenobarbitone, Memphobarbitone, Primidone, Phenytoin, Carbamazepine, Ethosuximide, Valporic acid (Sodium valporate), Diazepam, Lamotrigine, Gabapentin, Bigabatrin, Phenacemide, Trimethadione and Acetazolamide	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049082	Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Other Antiepileptic drugs	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049083	Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Sulpha drugs not elsewhere specified or included	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049084	Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Preparations of Enzymes	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049085	Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Veterinary medicinal preparations, not for human use, not elsewhere specified or included	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049086	Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Oral rehydration salts	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049087	Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Antibacterial formulations, not elsewhere specified or included	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049088	Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Sedatives	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049089	Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Tranquilizers	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049091	Other: ---- Salbutamol, Terbutaline, Ephedrine, Salmeterol and Methyl xanthimes	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049092	Other: ---- Plasma expanders	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049093	Other: ---- Chloropheniramine Maleate, with or without other compounds (excluding steriods and alkaloids)	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049094	Other: ---- Theophylline, Aminophylline and other Broncho dilators	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049095	Other: ---- Carcino-chemotherapeutic drugs not elsewhere specified or included	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	30049096	Other: ---- Ketamine	---	Free	Subject to Policy Condition 1 of the Chapter Furthermore, export of Ketamine is allowed subject to obtaining No Objection Certificate from Narcotics Commissioner	06/2023	22.05.2023
30	30049099	Other: ---- Other	---	Free	Subject to Policy Condition 1 of the Chapter	06/2023	22.05.2023
30	3005	Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
30	300510	Adhesive dressings and other articles having an adhesive layer	-
30	30051010	Adhesive guaze	---	Free
30	30051020	Adhesive tape	---	Free
30	30051090	Other	---	Free
30	300590	Other	-	Free
30	30059010	Cotton wool, medicated	---	Free
30	30059020	Poultice of Kaolin	---	Free		39/2015-2020	14.10.2021
30	30059030	Lint, medicated	---	Free		39/2015-2020	14.10.2021
30	30059040	Bandages	---	Free		39/2015-2020	14.10.2021
30	30059050	Burn therapy dressing soaked in protective gel	---	Free		39/2015-2020	14.10.2021
30	30059060	Micro pores surgical tapes	---	Free		39/2015-2020	14.10.2021
30	30059070	Corn removers and callous removers	---	Free		39/2015-2020	14.10.2021
30	30059090	Other	---	Free		39/2015-2020	14.10.2021
30	3006	Pharmaceutical goods specified in Note 4 to this Chapter.				39/2015-2020	14.10.2021
30	300610	Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable	-	Free		39/2015-2020	14.10.2021
30	30061010	Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure	---	Free
30	30061020	sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable	---	Free
30	30063000	Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient	-	Free
30	30064000	Dental cements and other dental fillings; bone reconstruction cements	-	Free
30	30065000	First-aid boxes and kits	-	Free
30	300660	Chemical contraceptive preparations based on hormones, on other products of heading 29.37 or on spermicides	-
30	30066010	Based on hormones	---	Free
30	30066020	Based on other products of heading 2937	---	Free
30	30066030	Based on spermicides	---	Free
30	30067000	Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments	-	Free
30	30069100	Other : -- Appliances identifiable for ostomy use	-	Free
30	30069300	Cell cultures, whether or not modified - - Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses	-	Free